|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 213/02 | |
| C07D 401/02 | |||
| A61K 31/44 |
| (11) | Number of the document | 1838674 |
| (13) | Kind of document | T |
| (96) | European patent application number | 06718419.2 |
| Date of filing the European patent application | 2006-01-13 | |
| (97) | Date of publication of the European application | 2007-10-03 |
| (45) | Date of publication and mention of the grant of the patent | 2011-03-30 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2006/001341 |
| Date | 2006-01-13 |
| (87) | Number | WO 2006/076644 |
| Date | 2006-07-20 |
| (30) | Number | Date | Country code |
| 644103 P | 2005-01-14 | US | |
| 742821 P | 2005-12-06 | US | |
| 750985 P | 2005-12-16 | US |
| (72) |
UNGASHE, Solomon, US
WRIGHT, John, Jessen, AU
ZENG, Yibin, US
BADAK, Arindrajit, US
CHARVAT, Trevor, T., US
DAIRAGHI, Daniel, US
HANSEN, Derek, US
JIN, Jeff, US
MOORE, Jimmie, US
PENNELL, Andrew M.K., US
PUNNA, Sreenivas, US
WEI, Zheng, US
|
| (73) |
ChemoCentryx, Inc.,
850 Maude Avenue, Mountain View California 94043,
US
|
| (54) | HETEROARYL SULFONAMIDES AND CCR2 |
| HETEROARYL SULFONAMIDES AND CCR2 |